This invited review, co-authored with Dr. Stevie Barry, a Penn Internal Medicine resident, and Emily Sheng, a Penn medical student, explores the complex association between rheumatoid arthritis and metabolism, including both underlying mechanisms and clinical implications.
The topic is especially timely given the emergence of new obesity treatments and recent advances in the management of inflammatory arthritis. The editorial offers important insights into how metabolic factors intersect with chronic inflammatory disease and may influence future therapeutic strategies.